Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115920) titled 'The Impact of Adjuvant Therapy on Survival in Stage I Invasive Lung Adenocarcinoma with High-Risk Pathological Factors: A Retrospective Cohort Study' on Jan. 4.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Lung Cancer
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-01-05
Target Sample Size: Case group:800;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=300632
Disclaimer: Curated by HT Syndication....